Best breast cancer drug denied

by ROBIN YAPP, Daily Mail

Thousands of women with breast cancer are being denied a ground-breaking alternative to chemotherapy, it emerged.

Research shows that Zoladex is just as effective at preventing the return of cancer and has fewer side effects than chemotherapy.

More than three-quarters of women questioned in a survey said they would prefer the drug to the more widely used treatment, which can result in hair loss and infertility.

The side effects of Zoladex are menopausal symptoms such as hot flushes. Studies also indicate that if used in conjunction with another similar medication, Zoladex can increase the chances of surviving the disease.

Researchers say that only one in five women with breast cancer is offered the drug, as the medical profession has been slow to catch on to its benefits.

Up to 50 per cent of such patients use it in other parts of Europe. Professer Lesley Fallowfield, of Cancer Research UK, which conducted the survey, said: "It's outrageous that women are not being given the choice."

As a result, women could be left infertile through chemotherapy without even knowing that there is an alternative.

Research shows that Zoladex, which has been used for several years to treat advanced breast cancer, is equally as effective in the early stages of the disease.

No comments have so far been submitted. Why not be the first to send us your thoughts, or debate this issue live on our message boards.

We are no longer accepting comments on this article.

Who is this week's top commenter? Find out now